CenterBook Partners LP Takes $368,000 Position in Herbalife Ltd $HLF

CenterBook Partners LP purchased a new stake in shares of Herbalife Ltd (NYSE:HLF) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 43,550 shares of the company’s stock, valued at approximately $368,000.

Other large investors have also recently modified their holdings of the company. Y Intercept Hong Kong Ltd purchased a new position in shares of Herbalife in the second quarter worth $531,000. Fund 1 Investments LLC purchased a new position in shares of Herbalife during the second quarter valued at about $8,491,000. Optimize Financial Inc bought a new position in shares of Herbalife in the 3rd quarter worth approximately $511,000. Iridian Asset Management LLC CT raised its holdings in Herbalife by 9.9% in the third quarter. Iridian Asset Management LLC CT now owns 2,449,155 shares of the company’s stock worth $20,671,000 after purchasing an additional 220,896 shares in the last quarter. Finally, Hussman Strategic Advisors Inc. bought a new position in shares of Herbalife in the 3rd quarter worth about $532,000.

Herbalife Price Performance

HLF stock opened at $19.92 on Friday. The stock has a market capitalization of $2.06 billion, a P/E ratio of 9.05 and a beta of 0.84. Herbalife Ltd has a 1-year low of $6.20 and a 1-year high of $20.34. The business has a fifty day moving average price of $15.60 and a 200-day moving average price of $11.74.

Herbalife (NYSE:HLF) last released its quarterly earnings data on Wednesday, February 18th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.48 by ($0.03). Herbalife had a net margin of 4.53% and a negative return on equity of 35.02%. The business had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.24 billion. During the same period last year, the business earned $0.36 earnings per share. The company’s quarterly revenue was up 6.3% on a year-over-year basis. As a group, analysts anticipate that Herbalife Ltd will post 1.57 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms recently commented on HLF. Argus set a $15.00 price objective on shares of Herbalife in a research note on Wednesday, November 26th. Mizuho set a $13.00 price target on Herbalife and gave the stock a “neutral” rating in a research report on Thursday, January 8th. Maxim Group initiated coverage on Herbalife in a research report on Tuesday, January 6th. They set a “buy” rating and a $20.00 price objective for the company. Zacks Research upgraded Herbalife from a “hold” rating to a “strong-buy” rating in a research note on Thursday. Finally, Wall Street Zen raised Herbalife from a “hold” rating to a “buy” rating in a research note on Friday, November 28th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.60.

More Herbalife News

Here are the key news stories impacting Herbalife this week:

• Positive Sentiment: Cristiano Ronaldo purchased a disclosed minority stake (reported as ~10% of the Pro2col unit), which investors have treated as a credibility and growth signal for Herbalife’s wellness/tech spinout. Cristiano Ronaldo Invests $7.5 Million Into Herbalife—Stock Surges
• Positive Sentiment: Q4 revenue (≈$1.28–1.30B) topped consensus and the company issued FY/quarter guidance in line with or slightly above Street expectations — supporting the view that top-line growth is intact. Herbalife (NYSE:HLF) Beats Q4 CY2025 Sales Expectations, Stock Jumps 11.7%
• Positive Sentiment: Analysts and quant-rank services turned more constructive: Maxim reiterated a Buy and Zacks added HLF to its Rank #1 (Strong Buy) lists, boosting short-term demand from retail and model-driven funds. Buy Rating on Herbalife Driven by Turnaround Momentum… New Strong Buy Stocks for February 20th
• Positive Sentiment: Shares hit a 52-week / multi-year high on the combined impact of the deal news, better-than-expected net sales and increased volume — momentum that can attract momentum/trend traders. Herbalife (HLF) Climbs to 3-Year High on Net Sales Beat
• Neutral Sentiment: The full Q4 earnings call transcript and slide deck are available for investors who want detailed color on product innovation, distributor trends and digital personalization initiatives — useful for modeling longer-term growth but not an immediate catalyst by itself. Herbalife Q4 2025 earnings call transcript
• Negative Sentiment: Mixed profitability signals: while revenue and operating cash flow grew, reported EPS metrics missed some consensus figures and the company showed year-over-year declines in operating profit and net income, which raises questions about margin recovery. Herbalife Ltd. (HLF) stock rises on Q4 2025 Earnings
• Negative Sentiment: Some outlets flagged an EPS miss versus consensus and a negative ROE / thin net margin — fundamentals investors watch for sustained valuation support. Herbalife Ltd (HLF) Misses Q4 Earnings and Revenue Estimates

About Herbalife

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.